Guardant Health, Inc. (GH)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Guardant Health, Inc. (GH)
Go deeper and ask any question about GH
Company Performance
Current Price
as of Sep 13, 2024$26.79
P/E Ratio
N/A
Market Cap
$3.3B
Description
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2011 and is headquartered in Palo Alto, CA.
Metrics
Overview
- HQPalo Alto, CA
- SectorHealth Services
- IndustryMedical/Nursing Services
- TickerGH
- Price$26.79+4.73%
Trading Information
- Market Cap$3.30B
- Float95.03%
- Average Daily Volume (1m)2,344,816
- Average Daily Volume (3m)2,120,186
- EPS-$4.09
Company
- Revenue$643.81M
- Rev Growth (1yr)29.23%
- Net Income-$102.63M
- Gross Margin59.14%
- EBITDA Margin-50.73%
- EBITDA-$89.92M
- EV$3.84B
- EV/Revenue5.97
- P/EN/A
- P/S5.10
Documents
SEC Filings
Earnings Calls
Factset Street Account